What We're Reading: Page 229
Industry reads hand-picked by our editors
Sep 27, 2019
Sep 26, 2019
-
The Wall Street Journal
Health-Care Investor to Build Biotech Labs in Nomad
-
The Washington Post
Shuping Wang, whistleblower who exposed China's HIV/AIDS crisis, dies at 59
-
The Independent
Labour would found state drug company to make medicines cheaper
-
Bloomberg
Takeda Is Close to Selling Emerging Market, European Drugs
Sep 25, 2019
-
Vantage
Does amount matter when it comes to a biotech IPO?
-
The Washington Post
Why the cancer ‘moonshot’ has been so disappointing
-
The Wall Street Journal
A Big Biotech Bet Hiding in Plain Sight
Sep 24, 2019
Sep 23, 2019
-
CNN
Opioid-maker Purdue Pharma is allowed bonus payout in bankruptcy case
-
Endpoints
Genentech submits a big plan to expand its South San Francisco footprint
-
Financial Times
New allies fight Africa's deadly scourge of fake medicines
-
The Washington Post
As off-label use spreads for lifesaving niche drugs, supplies grow scarce, leaving patients in the lurch
Sep 20, 2019
-
Health Affairs
Understanding The House Democrats’ Drug Pricing Package
-
The Wall Street Journal
You've survived cancer. What comes next?
-
Associated Press
Will combo pill catch on in US to prevent heart attacks?
-
Bloomberg
The New Capitalism Is Looking a Lot Like the Old Capitalism
Previous
